Latest filing published 07 Jan 2015 for Arrowhead Pharmaceuticals, INC., €25k.
Insider track record
No signal scores available.
David L. Lewis: trading record in brief
All filings by David L. Lewis on record concern Arrowhead Pharmaceuticals, Inc. In total, 8 filings cover trades dated from 2 January 2014 to 5 January 2015.
Sales make up the whole of the open-market record (3 sales, €391k). Outside the open market, there are 5 option exercises. So far in 2015, the count stands at no purchases and 1 sale.
The record was last updated on 7 January 2015 with an option exercise (€25k) in Arrowhead Pharmaceuticals, Inc. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to David L. Lewis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,000 shares@ US$2.01Common StockSEC:0001181431-15-000623:0
- 15,000 shares@ US$8.01Common StockSEC:0001181431-15-000623:1
- 15,000 shares@ US$2.01Common StockSEC:0001181431-14-032835:0
- 15,000 shares@ US$15.02Common StockSEC:0001181431-14-032835:1
- 10,000 shares@ US$4.60Common StockSEC:0001181431-14-001415:0
- 2,500 shares@ US$5.19Common StockSEC:0001181431-14-001415:1
- 2,500 shares@ US$2.62Common StockSEC:0001181431-14-001415:2
- 15,000 shares@ US$10.29Common StockSEC:0001181431-14-001415:3
8 of 8 declarations
